46 related articles for article (PubMed ID: 19836771)
1. Cell signaling in kidney cancer.
Adam R
J Urol; 2009 Dec; 182(6):2555-6. PubMed ID: 19836771
[No Abstract] [Full Text] [Related]
2. Phosphatidylinositol-3-kinase/Akt signaling pathway and kidney cancer, and the therapeutic potential of phosphatidylinositol-3-kinase/Akt inhibitors.
Porta C; Figlin RA
J Urol; 2009 Dec; 182(6):2569-77. PubMed ID: 19836781
[TBL] [Abstract][Full Text] [Related]
3. Editorial comment.
Oya M
J Urol; 2009 Dec; 182(6):2577. PubMed ID: 19836782
[No Abstract] [Full Text] [Related]
4. Akt signaling and growth of the heart.
Walsh K
Circulation; 2006 May; 113(17):2032-4. PubMed ID: 16651482
[No Abstract] [Full Text] [Related]
5. Comment on "Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathway".
Wang W; Sun W; Zhang L
J Immunol; 2009 Aug; 183(4):2203; author reply 2203-4. PubMed ID: 19661264
[No Abstract] [Full Text] [Related]
6. Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes.
Cocco L; Faenza I; Follo MY; Ramazzotti G; Gaboardi GC; Billi AM; Martelli AM; Manzoli L
Adv Enzyme Regul; 2008; 48():2-9. PubMed ID: 18280812
[No Abstract] [Full Text] [Related]
7. Supressing the supressors.
Ohashi PS; Yeh WC
Nat Med; 2006 Sep; 12(9):1000-2. PubMed ID: 16960572
[No Abstract] [Full Text] [Related]
8. Prohibitin interacts with phosphatidylinositol 3,4,5-triphosphate (PIP3) and modulates insulin signaling.
Ande SR; Mishra S
Biochem Biophys Res Commun; 2009 Dec; 390(3):1023-8. PubMed ID: 19854158
[TBL] [Abstract][Full Text] [Related]
9. Calcium-independent phospholipase A2beta-Akt signaling is involved in lipopolysaccharide-induced NADPH oxidase 1 expression and foam cell formation.
Lee SH; Park DW; Park SC; Park YK; Hong SY; Kim JR; Lee CH; Baek SH
J Immunol; 2009 Dec; 183(11):7497-504. PubMed ID: 19917703
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
[TBL] [Abstract][Full Text] [Related]
11. Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes.
Choudhary C; Olsen JV; Brandts C; Cox J; Reddy PN; Böhmer FD; Gerke V; Schmidt-Arras DE; Berdel WE; Müller-Tidow C; Mann M; Serve H
Mol Cell; 2009 Oct; 36(2):326-39. PubMed ID: 19854140
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
13. Why do phosphatidylinositol kinases have so many isoforms?
Min SH; Abrams CS
Biochem J; 2009 Sep; 423(1):e5-8. PubMed ID: 19740077
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection against spinal cord ischemia-reperfusion injury induced by different ischemic postconditioning methods: roles of phosphatidylinositol 3-kinase-Akt and extracellular signal-regulated kinase.
Jiang X; Ai C; Shi E; Nakajima Y; Ma H
Anesthesiology; 2009 Dec; 111(6):1197-205. PubMed ID: 19934862
[TBL] [Abstract][Full Text] [Related]
15. Thrombin stimulates RPE cell proliferation by promoting c-Fos-mediated cyclin D1 expression.
Parrales A; Palma-Nicolás JP; López E; López-Colomé AM
J Cell Physiol; 2010 Feb; 222(2):302-12. PubMed ID: 19847806
[TBL] [Abstract][Full Text] [Related]
16. mTOR inhibition, AKT proteins and chronic kidney disease.
Márquez E; Pascual J
Nefrologia; 2014; 34(4):425-7. PubMed ID: 25036055
[No Abstract] [Full Text] [Related]
17. Chronic kidney disease: after nephron reduction, podoctyes get in on the AKT.
Kirk R
Nat Rev Nephrol; 2013 Nov; 9(11):624. PubMed ID: 24080798
[No Abstract] [Full Text] [Related]
18. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
Kawakami K; Hirata H; Yamamura S; Kikuno N; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
Cancer Res; 2009 Nov; 69(22):8603-10. PubMed ID: 19887605
[TBL] [Abstract][Full Text] [Related]
19. New mTOR inhibitor for renal cell cancer.
Wilkes GM
Oncology (Williston Park); 2009 Jul; 23(8 Suppl):54-6. PubMed ID: 19860046
[No Abstract] [Full Text] [Related]
20. Angiosarcoma of kidney: a case report and review of literature.
Papadimitriou VD; Stamatiou KN; Takos DM; Adamopoulos VM; Heretis IE; Sofras FA
Urol J; 2009; 6(3):223-5. PubMed ID: 19711281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
